We've found
4,882
archived clinical trials in
Obesity Weight Loss
We've found
4,882
archived clinical trials in
Obesity Weight Loss
Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding
Updated: 3/16/2016
Multicenter Prospective Randomized Clinical Trial of Plicated Laparoscopic Adjustable Gastric Banding
Status: Enrolling
Updated: 3/16/2016
Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding
Updated: 3/16/2016
Multicenter Prospective Randomized Clinical Trial of Plicated Laparoscopic Adjustable Gastric Banding
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Consequences of Obstructive Sleep Apnea on Respiratory Function Following Weight-loss Surgery
Updated: 3/16/2016
Consequences of Obstructive Sleep Apnea on Respiratory Function Following Weight-loss Surgery: A Randomized Controlled Trial
Status: Enrolling
Updated: 3/16/2016
Consequences of Obstructive Sleep Apnea on Respiratory Function Following Weight-loss Surgery
Updated: 3/16/2016
Consequences of Obstructive Sleep Apnea on Respiratory Function Following Weight-loss Surgery: A Randomized Controlled Trial
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Nutrition Intervention for the Promotion of Healthy Weight Gain During Pregnancy
Updated: 3/18/2016
Nutrition Intervention for the Promotion of Healthy Weight Gain During Pregnancy: The Revere Pregnancy Weight Management Study
Status: Enrolling
Updated: 3/18/2016
Nutrition Intervention for the Promotion of Healthy Weight Gain During Pregnancy
Updated: 3/18/2016
Nutrition Intervention for the Promotion of Healthy Weight Gain During Pregnancy: The Revere Pregnancy Weight Management Study
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Effects of Aerobic Exercise Detraining
Updated: 3/21/2016
Effects of Aerobic Exercise Detraining on Energy Balance in Overweight Persons
Status: Enrolling
Updated: 3/21/2016
Effects of Aerobic Exercise Detraining
Updated: 3/21/2016
Effects of Aerobic Exercise Detraining on Energy Balance in Overweight Persons
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
Metabolic Fuels Study
Updated: 3/21/2016
A Mechanistic Examination of Dietary Composition on Metabolic Fuels Availability
Status: Enrolling
Updated: 3/21/2016
Metabolic Fuels Study
Updated: 3/21/2016
A Mechanistic Examination of Dietary Composition on Metabolic Fuels Availability
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
Metabolic Fuels Study
Updated: 3/21/2016
A Mechanistic Examination of Dietary Composition on Metabolic Fuels Availability
Status: Enrolling
Updated: 3/21/2016
Metabolic Fuels Study
Updated: 3/21/2016
A Mechanistic Examination of Dietary Composition on Metabolic Fuels Availability
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
Metabolic Fuels Study
Updated: 3/21/2016
A Mechanistic Examination of Dietary Composition on Metabolic Fuels Availability
Status: Enrolling
Updated: 3/21/2016
Metabolic Fuels Study
Updated: 3/21/2016
A Mechanistic Examination of Dietary Composition on Metabolic Fuels Availability
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
Metabolic Fuels Study
Updated: 3/21/2016
A Mechanistic Examination of Dietary Composition on Metabolic Fuels Availability
Status: Enrolling
Updated: 3/21/2016
Metabolic Fuels Study
Updated: 3/21/2016
A Mechanistic Examination of Dietary Composition on Metabolic Fuels Availability
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
Energy Expenditure of High Intensity Functional Training
Updated: 3/22/2016
Energy Expenditure of High Intensity Functional Training
Status: Enrolling
Updated: 3/22/2016
Energy Expenditure of High Intensity Functional Training
Updated: 3/22/2016
Energy Expenditure of High Intensity Functional Training
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials
Weight Watchers Online 2015
Status: Enrolling
Updated: 3/28/2016
Updated: 3/28/2016
Weight Watchers Online 2015
Status: Enrolling
Updated: 3/28/2016
Updated: 3/28/2016
Click here to add this to my saved trials
Weight Watchers Online 2015
Status: Enrolling
Updated: 3/28/2016
Updated: 3/28/2016
Weight Watchers Online 2015
Status: Enrolling
Updated: 3/28/2016
Updated: 3/28/2016
Click here to add this to my saved trials
Calorie Reduction Or Surgery: Seeking Remission for Obesity And Diabetes
Updated: 3/29/2016
Feasibility, Efficacy, and Mechanisms of Surgical vs Medical Diabetes Treatment
Status: Enrolling
Updated: 3/29/2016
Calorie Reduction Or Surgery: Seeking Remission for Obesity And Diabetes
Updated: 3/29/2016
Feasibility, Efficacy, and Mechanisms of Surgical vs Medical Diabetes Treatment
Status: Enrolling
Updated: 3/29/2016
Click here to add this to my saved trials
Calorie Reduction Or Surgery: Seeking Remission for Obesity And Diabetes
Updated: 3/29/2016
Feasibility, Efficacy, and Mechanisms of Surgical vs Medical Diabetes Treatment
Status: Enrolling
Updated: 3/29/2016
Calorie Reduction Or Surgery: Seeking Remission for Obesity And Diabetes
Updated: 3/29/2016
Feasibility, Efficacy, and Mechanisms of Surgical vs Medical Diabetes Treatment
Status: Enrolling
Updated: 3/29/2016
Click here to add this to my saved trials
Tailored Lifestyle Intervention in Obese Adults Within Primary Care Practice - Choose to Lose
Updated: 3/31/2016
Tailored Lifestyle Intervention in Obese Adults Within Primary Care Practice
Status: Enrolling
Updated: 3/31/2016
Tailored Lifestyle Intervention in Obese Adults Within Primary Care Practice - Choose to Lose
Updated: 3/31/2016
Tailored Lifestyle Intervention in Obese Adults Within Primary Care Practice
Status: Enrolling
Updated: 3/31/2016
Click here to add this to my saved trials
Brighter Bites - Access, Continuity and Education With Fruits and Vegetables
Updated: 3/31/2016
Brighter Bites - Access, Continuity and Education With Fruits and Vegetables
Status: Enrolling
Updated: 3/31/2016
Brighter Bites - Access, Continuity and Education With Fruits and Vegetables
Updated: 3/31/2016
Brighter Bites - Access, Continuity and Education With Fruits and Vegetables
Status: Enrolling
Updated: 3/31/2016
Click here to add this to my saved trials
Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function
Updated: 4/1/2016
Modifiable Effectors of Renin System Activation: Treatment Evaluation (MODERATE)
Status: Enrolling
Updated: 4/1/2016
Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function
Updated: 4/1/2016
Modifiable Effectors of Renin System Activation: Treatment Evaluation (MODERATE)
Status: Enrolling
Updated: 4/1/2016
Click here to add this to my saved trials
Impact of Black Pepper on Energy Expenditure and Substrate Utilization
Updated: 4/5/2016
A Randomized, Cross-Over Trial to Evaluate the Acute Effects of Black Pepper on Energy Expenditure and Fat Oxidation in Humans
Status: Enrolling
Updated: 4/5/2016
Impact of Black Pepper on Energy Expenditure and Substrate Utilization
Updated: 4/5/2016
A Randomized, Cross-Over Trial to Evaluate the Acute Effects of Black Pepper on Energy Expenditure and Fat Oxidation in Humans
Status: Enrolling
Updated: 4/5/2016
Click here to add this to my saved trials
Outcomes Comparison Between Gastric Band, Laparoscopic Sleeve Gastrectomy and Gastric Bypass Surgeries in Obese Adolescents
Updated: 4/6/2016
Outcomes Comparison Between Gastric Band, Laparoscopic Sleeve Gastrectomy, and Gastric Bypass Surgeries in Obese Adolescents
Status: Enrolling
Updated: 4/6/2016
Outcomes Comparison Between Gastric Band, Laparoscopic Sleeve Gastrectomy and Gastric Bypass Surgeries in Obese Adolescents
Updated: 4/6/2016
Outcomes Comparison Between Gastric Band, Laparoscopic Sleeve Gastrectomy, and Gastric Bypass Surgeries in Obese Adolescents
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
Childhood Obesity: Variations in Management
Updated: 4/6/2016
Childhood Obesity: Variations in Management
Status: Enrolling
Updated: 4/6/2016
Childhood Obesity: Variations in Management
Updated: 4/6/2016
Childhood Obesity: Variations in Management
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Naltrexone/Bupropion Cardiovascular Outcomes Study
Updated: 4/7/2016
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials